Tag: VE416

EAT Grand Challenge

End Allergies Together Announces Winners of $1 Million Grand Challenge to...

New microbiome treatments and targets win Challenge as decided by distinguished panel of scientists, investors and entrepreneurs.
Bacteria

Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food...

First clinical study of a bacterial consortium for treating food allergy will initially be studied in patients with history of peanut allergy.
Vedanta Immunomodulator

Company Developing Microbiome-Derived Food Allergy Therapy Raises $27 Million

Product candidate being developed may safely induce permanent tolerance to food allergens.